PDSB - PDS Biotechnology Corp
1.16
-0.030 -2.586%
Share volume: 131,898
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.19
-0.03
-0.03%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-15-2024 | 08-14-2023 | 11-14-2023 | 11-14-2024 | 05-15-2024 | 08-13-2024 | 11-14-2024 | 03-27-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 9.422 M | 12.696 M | 10.520 M | 10.407 M | 10.098 M | 8.684 M | 10.179 M | 7.361 M | |
| Selling general and admin | 3.579 M | 4.691 M | 4.071 M | 2.941 M | 3.393 M | 4.157 M | 3.375 M | 2.831 M | |
| Research and development | 5.844 M | 8.005 M | 6.449 M | 7.466 M | 6.704 M | 4.528 M | 6.804 M | 4.530 M | |
| Total expenses | 9.422 M | 12.696 M | 10.520 M | 10.407 M | 10.098 M | 8.684 M | 10.179 M | 7.361 M | |
| 34.74% | -17.14% | -1.07% | -2.97% | -14.00% | 17.21% | -27.69% | |||
| Operating income | -9.422 M | -12.696 M | -10.520 M | -10.407 M | -10.098 M | -8.684 M | -10.179 M | -7.361 M | |
| Ebit | -9.422 M | -12.696 M | -10.520 M | -10.407 M | -10.098 M | -8.684 M | -10.179 M | -7.361 M | |
| Pretax income | -9.660 M | -12.941 M | -10.849 M | -10.898 M | -10.603 M | -9.197 M | -10.727 M | -7.952 M | |
| 33.97% | -16.16% | 0.45% | -2.70% | -13.26% | 16.63% | -25.86% | |||
| Income tax | 0.000 | -1.406 M | 0.000 | 0.000 | 0.000 | -869.169 K | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -9.660 M | -11.535 M | -10.849 M | -10.898 M | -10.603 M | -8.328 M | -10.727 M | -7.952 M | |
| -19.41% | 5.94% | -0.45% | 2.70% | 21.46% | -28.80% | 25.86% |
